TibaRay is highlighted among the cutting-edge firms displayed on one of the globe’s most iconic digital screens
Our team has spent years working toward a future where cancer treatment is faster, more precise and more accessible for patients around the world.”— Thinh Tran, CEO of TibaRaySILICON VALLEY, CA, UNITED STATES, July 29, 2026 /EINPresswire.com/ — Today, the Silicon Valley medical technology firm TibaRay was showcased on the Nasdaq Tower in New York’s Times Square after being chosen by Lehigh University’s Startup Academy, marking its advancement toward bringing next-generation precision radiation therapy to market. This recognition follows several recent achievements for the company, including further development of its Galactica™ system, as the Stanford-originated enterprise strives to deliver novel cancer treatment options to patients.
This feature positions TibaRay among the innovative businesses spotlighted on one of the world’s most well-known digital displays, highlighting the company’s progress and growing profile within the medtech sector. The opportunity arose from TibaRay’s collaboration with Lehigh University’s Startup Academy, which chose the firm for the billboard due to its novel strategy for improving cancer therapy and its dedication to entrepreneurship.
Rooted in research from Stanford University, TibaRay is creating Galactica, an upright linear accelerator radiation therapy platform aimed at enhancing patient ease while providing extremely targeted cancer treatment within a more compact and efficient system. This platform also establishes the foundation for future FLASH technology, an emerging cancer therapy method that administers radiation in under one second and has demonstrated the ability to effectively destroy tumors while limiting harm to adjacent healthy tissue.
"Every milestone brings us one step closer to making the next generation of radiation therapy available to patients," said Thinh Tran, CEO of TibaRay. "Our team has spent years working toward a future where cancer treatment is faster, more precise and more accessible for patients around the world. Being featured on the Nasdaq Tower is an exciting moment that reinforces our commitment to bringing this innovative technology to the patients who need it most."
Radiation therapy is employed in treating nearly half of all cancer patients, emphasizing the need for ongoing innovation that boosts precision, efficiency, and patient experience. As TibaRay moves forward toward commercialization, the company stays dedicated to hastening the creation of next-generation radiation therapy technologies that could improve outcomes, increase access to advanced cancer care, and influence the future of oncology.
Those interested in supporting TibaRay’s continued expansion can find details about its present investment opportunity at Wefunder.com/TibaRay. For further information, visit TibaRay.com.
###
About TibaRay
TibaRay is a medical technology company advancing innovative linear accelerator technology for radiotherapy and other commercial applications. The company’s next-generation accelerator platform is designed to help physicians deliver radiotherapy with greater precision, speed, and efficiency, while also supporting broader uses of compact, high-performance linear accelerators beyond cancer care.
Founded on technology developed at Stanford University, TibaRay brings together expertise in physics, engineering, and medicine to advance the future of radiation technology. Headquartered in Fremont, California, TibaRay is driven by its mission of Curing Cancer in a FLASH™. To learn more, visit TibaRay.com.
###
Karla Nafarrate
InnoVision Marketing Group
email us here
